Financials
- Market Capitalization 32.04 B
- Employee 2 500
- Founded 2002
- CEO Yvonne Greenstreet
- Website www.alnylam.com
- Headquarter Massachusetts, United States
- FIGI BBG000BFGNJ5
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
56.06
Rapporto prezzo/fatturato
8.6
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 277 | MRNA Moderna, Inc. - Common Stock | 149.01 USD | +6.18% | -4.99% | +171.27% | +522.69% | 59.49 B USD | ||
| 352 | RVMD Revolution Medicines, Inc. - Common Stock | 208.31 USD | +1.33% | -1.96% | +12.95% | +276.01% | 44.65 B USD | ||
| 482 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 62.19 USD | +1.27% | +0.57% | +7.11% | +66.91% | 27.77 B USD | ||
| 494 | INSM Insmed Incorporated - Common Stock | 120.83 USD | -0.81% | -4.14% | +23.04% | -25.44% | 26.39 B USD |